2024 Avoca Quality Consortium Summit
The industry is undergoing a transformation. With increasingly complex trial designs, tighter timelines, multiple systems requiring collaboration and integration, financial pressures, and fewer personnel resources, we need to accomplish more in less time. It’s imperative to re-evaluate traditional approaches to clinical trials and make dynamic shifts. This year’s AQC Summit features experiences, insights, ideas, and actions the clinical trial industry can use to transform and thrive.
Session information:
Title: Artificial Intelligence Discussion: How to Leverage AI to Maximize Time
Date: Tuesday, May 14, 2024
Time: 10:30 a.m. – 11:15 a.m. ET
Abstract:
Advances in AI technology provide numerous opportunities for maximizing time in a clinical research industry significantly impacted by a discerning financial environment. Join this executive panel as they discuss where the application of AI can be leveraged to alleviate current challenges.
Facilitator:
- Silvio Galea – Chief Data & Analytics Officer at WCG
Panelists:
- Anya Derbij, M.D. – Vice President, Head Clinical Operations at Cellphire Therapeutics, Inc.
- Jay Ferro – Executive Vice President, Chief Information, Technology and Product Officer at Clario
- Maxwell Lawson – Head of Digital Process Innovation and AI in Drug Development at Novartis
- Andrew Mackinnon – Senior Vice President & Executive General Manager at Medable
Speaker
Jay Ferro
Chief Information, Technology and Product Officer at Clario
Always striving for excellence, Jay heads up Clario’s development, information technology and strategic sourcing initiatives. With over 25 years’ experience of working as a global technology leader, Jay has a wealth of knowledge which helps drive changes that are critical to managing data protection. An expert in improving and implementing data policies, Jay is well placed to ensure the complete privacy and protection of data belonging to Clario’s customers and patients.